STAT3 and central nervous system cancer: Accordingly to the new strict and previously unexplored directionality CB1→STAT3, in our experimental model the differential effect of SR141716 on primary glioma growth occurred in concert with the differential changes of CB1 expression in tumor tissues and consequently with basal activated STAT3 levels.